Strategic Expertise for Differentiated Pharmaceutical Products
From early opportunity identification to commercial and intellectual property assessment, Kadstar provides strategic guidance to help define and evaluate pharmaceutical product concepts.
Our services are designed to bring scientific insight, market understanding, and strategic clarity together.
Comprehensive Pharmaceutical Program Specifications
A disciplined six-pillar strategic engagement model tailored to de-risk investments, accelerate lifecycle value, and secure unassailable market differentiation.
505(b)(2) Product Opportunity Assessment
We identify and evaluate differentiated pharmaceutical product concepts through formulation innovation, dosage-form changes, combination products, and other relevant product strategies.
- ■Opportunity identification and screening
- ■Product differentiation assessment
- ■Therapeutic and scientific rationale
- ■Strategic development considerations
- ■Opportunity prioritization
Product Lifecycle & Formulation Strategy
We explore opportunities to enhance existing product concepts through formulation innovation, alternative dosage forms, and lifecycle-focused strategies.
- ■Reformulation opportunities
- ■Modified-release concepts
- ■New strengths and dosage forms
- ■Long-acting delivery systems
- ■Combination product concepts
- ■Lifecycle opportunity assessment
Therapeutic & Scientific Rationale
We establish a scientific foundation for product opportunities by evaluating therapeutic needs, existing treatment approaches, and potential differentiation.
- ■Disease and patient context
- ■Current standard-of-care assessment
- ■Unmet medical needs
- ■Treatment and compliance limitations
- ■Proposed product concept evaluation
- ■Potential clinical differentiation
Business & Market Assessment
We assess the commercial context of pharmaceutical opportunities to understand their potential value, competitive position, and development considerations.
- ■Market size and growth analysis
- ■Geographic and customer segmentation
- ■Competitive landscape assessment
- ■Pricing assumptions
- ■Development investment mapping
- ■COGS and revenue scenarios
- ■Portfolio fit and licensing potential
IP Landscape & Strategic Guidance
We assess relevant intellectual property landscapes to identify potential differentiation areas, strategic considerations, and questions requiring further legal evaluation.
- ■Relevant patents and applications
- ■Patent holders and expiry timelines
- ■Potential patent white spaces
- ■Design-around opportunities
- ■Formulation and process considerations
- ■Combination and use concepts
- ■Delivery architecture assessment
- ■Potential IP routes and key risks
Regulatory & Legal Notice: Kadstar provides strategic IP landscape assessment and guidance. Formal legal opinions are provided by qualified IP counsel.
Strategic Development Partnerships
We help define opportunities and align the responsibilities of development partners across the pharmaceutical product development pathway.
- ■Opportunity definition and prioritization
- ■Partner role alignment
- ■Development responsibility mapping
- ■Regulatory and manufacturing coordination considerations
- ■Licensing and commercialization pathway discussions
One Connected Framework. Multiple Strategic Perspectives.
Our services are interconnected, enabling each opportunity to be considered through scientific, commercial, product, and intellectual property lenses.
Opportunity Identification
Scientific & Therapeutic Assessment
Commercial & Market Evaluation
IP Landscape & Strategic Guidance
Opportunity Prioritization & Partner Alignment
Let's Define Your Next Pharmaceutical Opportunity.
Connect with Kadstar to explore product concepts, strategic assessments, and potential development partnerships.
Operating at the critical convergence of science, law, and capital allocation across global jurisdictions.